this post was submitted on 17 Jul 2023
8 points (100.0% liked)

Science

18 readers
2 users here now

This magazine is dedicated to discussions on scientific discoveries, research, and theories across various fields, including physics, chemistry, biology, astronomy, and more. Whether you are a scientist, a science enthusiast, or simply curious about the world around us, this is the place for you. Here you can share your knowledge, ask questions, and engage in discussions on a wide range of scientific topics. From the latest breakthroughs to historical discoveries and ongoing research, this category covers a wide range of topics related to science.

founded 1 year ago
 

The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

top 5 comments
sorted by: hot top controversial new old
[–] FaceDeer@kbin.social 4 points 1 year ago

The results regarding amyloid plaques just keep going back and forth over time, I'm very curious how this will ultimately play out. I suppose even if the plaques are a symptom rather than the underlying cause it can still be helpful clearing them away.

[–] BoCanCan@kbin.social 4 points 1 year ago (1 children)

It delays dementia by 4-7 months, and also causes bleeding and swelling in the brain which killed 3 out of 1,700 participants in the study.

It’s better than nothing I guess but it’s not a particularly good treatment.

[–] OptimisticPrime@lemmy.fmhy.ml 2 points 1 year ago* (last edited 1 year ago)

Sure, but treatments of something that complex has to start somewhere. It seems to go in the right direction and upcoming treatments may build on that. I am not sure that anyone could have expected after many failures to just find the magical cure that completely cures Alzheimers.

[–] claustrum@kbin.social 1 points 1 year ago* (last edited 1 year ago)

For anyone interested in neuroscience, https://kbin.social/m/neuro was just launched :)